Total Visits

Views
Initial results of a clinical trial evaluating a full-length pegylated recombinant factor viii with extended half-life for the perioperative control of hemostasis in hemophilia A40

Select a period of time:

Views

Views
October 20240
November 20241
December 20241
January 20250
February 20253
March 202516
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States3
United Kingdom2
 

Top cities views

Views